about
Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasiaGonadotropin secreting pituitary adenoma associated with erythrocytosis: case report and literature review.Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center.AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up.Identification and characterization of heart-specific splicing of human neurexin 3 mRNA (NRXN3).A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype.A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC.The GIP/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of gsp- somatotropinomas.Activation of the dopamine receptor type-2 (DRD2) promoter by 9-cis retinoic acid in a cellular model of Cushing's disease mediates the inhibition of cell proliferation and ACTH secretion without a complete corticotroph-to-melanotroph transdifferentVenous thromboembolism in patients with Cushing's syndrome: need of a careful investigation of the prothrombotic risk profile.Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.In vivo delivery of naked antisense oligos in aged mdx mice: analysis of dystrophin restoration in skeletal and cardiac muscle.Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations.Large Genomic Rearrangements of Desmosomal Genes in Italian Arrhythmogenic Cardiomyopathy Patients.Characterization of a novel human gene containing ANK repeats and ARM domains.Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency.Novel mutations in the L1CAM gene support the complexity of L1 syndrome.Acromegaly Is More Severe in Patients With AHR or AIP Gene Variants Living in Highly Polluted Areas.Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study.Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1Paradoxical GH increase during OGTT is associated to first-generation somatostatin analogs responsiveness in acromegalySilent gonadotroph pituitary neuroendocrine tumor in a patient with tuberous sclerosis complex: evaluation of a possible molecular linkArrhythmogenic right ventricular cardiomyopathy type 1 (ARVD1): confirmation of locus assignment and mutation screening of four candidate genesThe usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imagingAdrenal nodules in patients with Cushing's disease: prevalence, clinical significance and follow-upNew insight into the hypercoagulability of Cushing's syndromeHomozygous Desmocollin-2 Mutations and Arrhythmogenic CardiomyopathyPerformance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiencyAn analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: a single-centre experienceA multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotypePerformance of four models for eye color prediction in an Italian population sampleThe pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetesA targeted next-generation gene panel reveals a novel heterozygous nonsense variant in the TP63 gene in patients with arrhythmogenic cardiomyopathy
P50
Q28284546-006E857D-DBE0-43F6-9D19-16CB9756FF07Q30798324-8D15386F-3F40-42FA-A3A6-A6A725C16CBCQ33419582-9D02B347-979D-4DDF-AB2F-36EE8FA51648Q33895577-C62D13FA-8B57-4EBC-AAA7-C27C7AC8A150Q34154357-AED91D99-8966-4BD5-93DF-42BE3CBC22F4Q34649802-FC4CFBD4-5B96-4D85-9F64-8252A7B53D5CQ36544784-0E68FA4E-DBC1-4B77-B3E2-32CEB6582AD7Q38717209-9D8F35D1-CA17-4FEF-9D77-28C232E115E5Q38985205-BA14EF1A-39B7-42AF-AE71-F339C6A92591Q43443005-2C182EED-7F5D-4B2D-B476-306ADA36286AQ44476584-2CE760B4-2BE6-4078-AFAD-8510D864E18BQ45054898-D25E3B96-E65A-4A24-877F-DD4347DBA448Q46649628-78786C4D-D455-4176-9BA5-8BDF3640A09BQ47644282-F3ED680A-C68B-4B4C-8BEB-8EF63C1A6B9DQ47694098-3FA692A7-6E7D-466D-8D0C-F6C2BD62B8E0Q50906754-2E063F24-CC0F-452A-A2D5-A7928F79EA37Q51851636-A80CC3A2-67C5-43AA-BA12-AE7C9512F507Q53793757-4F4187D5-BE7C-48D2-B06C-288EDC87E5B6Q53799921-C1CCD017-EA33-4E6D-92BD-9325CD8B2E63Q55670706-FFE9A35A-E286-48C0-A2C8-FAA76D856B5BQ57037753-4260AEEB-1268-4656-A442-873C22AEE899Q58713464-77E0D1B3-D887-46D8-9E0B-848C7F9954AFQ78800461-7852550C-361B-4035-B29E-268D5908E5E4Q79743319-C39DDE34-DA08-4711-B131-38430C64165CQ82508668-F37FE48A-1EA7-4170-806F-A31465A31852Q83389708-1A2ED6EF-2B84-45AF-9BC2-43E1C563B198Q86006391-0BC33956-643E-462F-A933-4DF6EDFD1FC2Q86642192-8C22F332-F7E3-4CCB-AC8A-D376060F3B20Q86848341-C9B279C2-D6E1-4199-A2EB-E241FF1C2FF5Q89256648-7A023D16-BBBE-4B1F-A4B7-2F43239B09E6Q92448380-94371ADD-AA3D-486A-93C8-6EA3AD0B3529Q92613514-AE71AC53-8B96-4B2B-AF35-26608D98A082Q93213387-A46A58AD-9DF7-4EB7-ABAB-2B9F7830F18F
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Gianluca Occhi
@ast
Gianluca Occhi
@en
Gianluca Occhi
@es
Gianluca Occhi
@nl
type
label
Gianluca Occhi
@ast
Gianluca Occhi
@en
Gianluca Occhi
@es
Gianluca Occhi
@nl
prefLabel
Gianluca Occhi
@ast
Gianluca Occhi
@en
Gianluca Occhi
@es
Gianluca Occhi
@nl
P1153
6603762575
P31
P496
0000-0003-4065-4677